James R. Kasinger, General Counsel and Secretary at CRISPR Therapeutics AG (CRSP), sold 3,826 shares at $79.67 ($305K) on 2024-02-20, disclosed to the SEC on 2024-02-21.
Open-market sale of $305k CRSP by General Counsel and Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.67 | 1,913 | $152K | 50.0% |
| 2 | $79.67 | 1,913 | $152K | 50.0% |
| Total | $79.67 avg | 3,826 | $305K | 100% |
| Filing → |
| CRSP | SELL | 2026-03-17 | $166K | — | Filing → |
| CRSP | SELL | 2026-03-12 | $148K | — | Filing → |
| CRSP | SELL | 2026-02-20 | $111K | — | Filing → |